News
Vasculitis in the News
An RSS (Really Simple Syndication) feed is a news aggregator that uses software to search the internet for content that contains specific keywords.This RSS feed contains articles related to all forms of vasculitis. The articles in this feed come from a variety of online sources and are not directly associated with the Vasculitis Foundation (VF). Inclusion of an article in this RSS feed does not imply endorsement of the content by the VF.
- Anti-neutrophil cytoplasmic antibody-associated vasculitis: biological insights and biomarker-guided disease management - Nature
- Nodular Vasculitis Following Aromatase Inhibitor Therapy for Breast Cancer: A Case Report - Cureus
- Phase 2 trial planned to test oral therapy izicopan in AAV - ANCA Vasculitis News
- Redefining intimacy in life with chronic illness - ANCA Vasculitis News
- InflaRx N.V. (IFRX) Discusses Strategic Focus on Izicopan for ANCA-Associated Vasculitis and Renal Diseases - Slideshow (NASDAQ:IFRX) 2026-05-08 - Seeking Alpha
- InflaRx Investor Update: Izicopan Set to Take Center Stage in AAV and Renal Disease Pipeline - TradingView
- InflaRx Unveils Izicopan Strategic Shift And $150m Offering - Citeline News & Insights
- Complex Challenges in ANCA-Associated Vasculitis: A Case of COVID-19, Cytomegalovirus Pneumonitis, and Hemorrhagic Cholecystitis Following Rituximab Therapy - Cureus
- Granulomatosis With Polyangiitis Presenting as Pulmonary Masses With Coexisting Infection: A Diagnostic Challenge Leading to Life-Threatening Pulmonary-Renal Syndrome - Cureus
- Q&A: Phase-Specific Relapse Predictors in ANCA-Associated Vasculitis - Physician's Weekly
- Advocates aim to foster connections this Vasculitis Awareness Month - ANCA Vasculitis News
- InflaRx Refocuses Izicopan on Vasculitis and Renal Diseases With Funding Runway to 2029 - TipRanks
- InflaRx (Nasdaq: IFRX) details izicopan kidney strategy and funding through 2029 - Stock Titan
- InflaRx Advances Development of Izicopan for ANCA-Associated Vasculitis and Broader Renal Diseases with Upcoming Capital Markets Day in Summer 2026 - Quiver Quantitative
- Funded through 2029, InflaRx expands izicopan into kidney diseases - Stock Titan
In Partnership With
ANCA Vasculitis News, a Bionews site, provides clear, reliable news, research updates, and real-world perspectives to help people living with ANCA vasculitis and their caregivers feel more informed, confident, and supported throughout their care journey. Information is not meant to replace medical advice.